📑Medicamentos diversos.
Procurement process summary
This process is to purchase Medicamentos diversos.
This contract was awarded by 🇪🇸 Servicio Madrileño de Salud (SERMAS) for an amount of EUR 256,807 to 1 supplier. It was published on 2015-08-05 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇸 Servicio Madrileño de Salud (SERMAS) Buying unitnot reported Publication date2015-08-05 Contest statusnot reported DescriptionAdquisicion de medicamentos diversos, distribuidos en 22 lotes.Awards
This award was granted to Boehringer Ingleheim España, S.A. by Servicio Madrileño de Salud (SERMAS) for an amount of EUR 256,807. The procurement process was conducted through open for the category of goods. This is award number 17.
This contract has multiple awards. This is award number 17. View other awards for this contract
| Supplier | Amount | Award number |
|---|---|---|
| 🇪🇸 Boehringer Ingleheim España, S.A. | EUR 256,807 | 17 |
Market context and opportunities
The execution of this contract allows the entity Servicio Madrileño de Salud (SERMAS) to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberES_ocds-70d2nz-55096870-a5bb-4d38-9407-e80ec025de89-award-17Publication date2015-08-05Contract datenot reportedAward datenot reportedCategoriesgoodsPurchase modalityopenMethod detailspt_openStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
